NCT00804297View on ClinicalTrials.gov

Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

January 31, 2007

Conditions
HypoglycemiaDiabetes Mellitus
Interventions
DRUG

Octreotide (drug)

Trial Locations (1)

19141

Albert Einstein Medical Center, Philadelphia

All Listed Sponsors
lead

Albert Einstein Healthcare Network

OTHER

NCT00804297 - Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia | Biotech Hunter | Biotech Hunter